Abstract:This working paper is hosted by The Berkeley Electronic Press (bepress) and may not be commercially reproduced without the permission of the copyright holder. Summary. Randomized clinical trials are a powerful tool for investigating causal treatment effects, but in human trials there are oftentimes problems of noncompliance which standard analyses, such as the intention-to-treat or as-treated analysis, either ignore or incorporate in such a way that the resulting estimand is no longer a causal effect. One alternative to these analyses is the complier average causal effect (CACE) which estimates the average causal treatment effect among a subpopulation that would comply under any treatment assigned. We focus on the setting of a randomized clinical trial with crossover treatment noncompliance (e.g., control subjects could receive the intervention and intervention subjects could receive the control) and outcome nonresponse. In this article, we develop estimators for the CACE using multiple imputation methods, which have been successfully applied to a wide variety of missing data problems, but have not yet been applied to the potential outcomes setting of causal inference. Using simulated data we investigate the finite sample properties of these estimators as well as of competing procedures in a simple setting. Finally we illustrate our methods using a real randomized encouragement design study on the effectiveness of the influenza vaccine. 1. Introduction The focus of empirical studies in medicine is often to estimate the causal effect of treatments, where randomized clinical trials are considered the most acceptable tool for investigating these causal relationships. But in trials involving human subjects there are oftentimes problems of patient noncompliance, where the patient does not adhere to the treatment assigned. In addition, there is also the problem of nonignorable missing data, where the missing-data mechanism may depend on unobserved data. Standard methods and analyses either ignore these complications, which can lead to biased estimates of causal treatment effect, or account for them in such a way that the resulting estimand can no longer be considered a causal effect of treatment. A statistical framework for causal inference that deals with the issue of noncompliance is based on potential outcomes and was first introduced by Neyman (1923) for randomized studies and later developed by Rubin (1974, 1978) for nonrandomized studies and other forms of inference. Rubin's approach, sometimes referred to as the Ru-bin Causal Model (Holland, 1986), provides a framework for defining the parameters of interest and correctly attributing the …

Two assumptions of the prior event rate ratio approach for controlling confounding can be evaluated by self-controlled case series and dynamic random intercept modelling

Incorporating Historical Information to Improve Phase I Clinical Trials

BASIC: A Bayesian Adaptive Synthetic-Control Design for Phase II Clinical Trials.

The probabilities of an outcome on intervention and control can be estimated by randomizing subjects to different testing strategies, required for assessing diagnostic tests, test trace and isolation and for natural randomisation

The covariate-adjusted residual estimator and its use in both randomized trials and observational settings

Adaptive Hybrid Control Design for Comparative Clinical Trials with Historical Control Data

Dynamic borrowing of historical controls adjusting for covariates in vaccine efficacy clinical trials

Triangulating Instrumental Variable, confounder adjustment and Difference-in-Difference methods for comparative effectiveness research in observational data

Is inverse probability of censoring weighting a safer choice than per-protocol analysis in clinical trials?

Estimation and reduction of bias in self‐controlled case series with non‐rare event dependent outcomes and heterogeneous populations

Propensity score-integrated Bayesian prior approaches for augmented control designs: a simulation study

Analysis approaches to address treatment nonadherence in pragmatic trials with point-treatment settings: a simulation study

Estimation of trajectory of protective efficacy in infectious disease prevention trials using recurrent event times

Efficient nonparametric inference on the effects of stochastic interventions under two-phase sampling, with applications to vaccine efficacy trials

Towards More Flexible False Positive Control in Phase III Randomized Clinical Trials

Simulation and inference on purely observational methods of monitoring vaccine effectiveness post-deployment: none is reliable without precise information on population behaviour

Series 2-19-2009 Multiple Imputation Methods for Treatment Noncompliance and Nonresponse in Randomized Clinical Trials

A Potential Outcomes, and Typically More Powerful, Alternative to 'Cochran-Mantel-Haenszel'

Assessing the impact of unmeasured confounders for credible and reliable real-world evidence

Factors Influencing Background Incidence Rate Calculation: Systematic Empirical Evaluation Across an International Network of Observational Databases

Grace periods and exposure misclassification in self-controlled case-series studies of drug-drug interactions